470 related articles for article (PubMed ID: 25838313)
1. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
Peng Y; Liu B; Hou J; Sun J; Hao R; Xiang K; Yan L; Zhang J; Zhuang H; Li T
Antivir Ther; 2015; 20(6):623-32. PubMed ID: 25838313
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversion during antiviral treatment.
Hao R; Xiang K; Peng Y; Hou J; Sun J; Li Y; Su M; Yan L; Zhuang H; Li T
Infect Genet Evol; 2015 Jul; 33():261-8. PubMed ID: 25976382
[TBL] [Abstract][Full Text] [Related]
3. The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response.
Peng Y; Li Y; Hou J; Sun J; Su M; Li Y; Xiang K; Yan L; Zhuang H; Li T
Infect Genet Evol; 2017 Apr; 49():116-121. PubMed ID: 28088502
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.
Yan CH; Zhao CY; Ding H; Peng YQ; Jin PY; Yan L; Zhuang H; Li T
Antiviral Res; 2012 Nov; 96(2):108-14. PubMed ID: 22960603
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
10. Significance of viral load, core promoter/precore mutations and specific sequences of polymerase gene in HBV-infected patients on 3-year lamivudine treatment.
Yuen MF; Sablon E; Libbrecht E; Van De Velde H; Wong DK; Fung J; Wong BC; Lai CL
Antivir Ther; 2006; 11(6):779-86. PubMed ID: 17310822
[TBL] [Abstract][Full Text] [Related]
11. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
12. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
Joshi SS; Gao S; Castillo E; Coffin CS
Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
[TBL] [Abstract][Full Text] [Related]
13. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
[TBL] [Abstract][Full Text] [Related]
15. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.
Honda A; Yokosuka O; Ehata T; Tagawa M; Imazeki F; Saisho H
J Med Virol; 1999 Apr; 57(4):337-44. PubMed ID: 10089043
[TBL] [Abstract][Full Text] [Related]
17. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
18. Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.
Yuen MF; Seto WK; Fung J; Wong DK; Yuen JC; Lai CL
Am J Gastroenterol; 2011 Jul; 106(7):1264-71. PubMed ID: 21364549
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma.
Venard V; Corsaro D; Kajzer C; Bronowicki JP; Le Faou A
J Med Virol; 2000 Oct; 62(2):177-84. PubMed ID: 11002246
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
